BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,524,169 | +56.0% | 704,383 | +54.9% | 9.85% | +47.9% |
| Q2 2023 | $49,066,597 | +13.2% | 454,615 | +30.6% | 6.66% | +53.6% |
| Q1 2023 | $43,346,000 | +10.1% | 347,965 | +32.8% | 4.34% | -10.0% |
| Q4 2022 | $39,368,306 | +8.1% | 262,071 | -3.0% | 4.82% | +16.3% |
| Q3 2022 | $36,425,288 | -18.8% | 270,057 | -10.2% | 4.14% | +6.2% |
| Q2 2022 | $44,838,000 | -34.6% | 300,721 | -25.2% | 3.90% | +31.8% |
| Q1 2022 | $68,606,000 | +365.3% | 402,239 | +603.3% | 2.96% | +229.6% |
| Q4 2021 | $14,744,000 | +2600.4% | 57,190 | +2759.5% | 0.90% | +2465.7% |
| Q3 2021 | $546,000 | -91.0% | 2,000 | -92.6% | 0.04% | -90.7% |
| Q2 2021 | $6,045,000 | -29.4% | 27,000 | -65.6% | 0.38% | -30.4% |
| Q1 2021 | $8,567,000 | +1006.8% | 78,460 | +725.9% | 0.54% | +721.2% |
| Q4 2020 | $774,000 | – | 9,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,038,674 | $85,000,000 | 19.42% |
| Artal Group S.A. | 1,000,000 | $81,520,000 | 1.75% |
| PARUS FINANCE (UK) Ltd | 49,210 | $4,012,000 | 1.17% |
| Ikarian Capital, LLC | 319,900 | $26,080,000 | 1.15% |
| Parametrica Management Ltd | 18,054 | $1,473,000 | 0.91% |
| ARMISTICE CAPITAL, LLC | 236,000 | $19,239,000 | 0.65% |
| SevenBridge Financial Group, LLC | 19,013 | $1,550,000 | 0.61% |
| Redmile Group, LLC | 580,746 | $47,342,000 | 0.57% |
| Redwood Investments, LLC | 82,246 | $6,705,000 | 0.57% |
| Paradigm Financial Advisors, LLC | 24,681 | $2,012,000 | 0.54% |